ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1688

Early Detection of Left Ventricular Morphological, Functional Abnormalities and Myocardial Characteristics in Systemic Sclerosis without Cardiac Symptoms Using Cardiac Magnetic Resonance Imaging: A Preliminary Report

Kaita Sugiyama1, Hitomi Kobayashi2, Yasuyuki Kobayashi3, Yosuke Nagasawa4, Natsumi Ikumi2, Takamasa Nozaki4, Hirotake Inomata2, Hidetaka Shiraiwa2, Hiromi Karasawa2, Noboru Kitamura4, Mitsuhiro Iwata4, Yoshihiro Matsukawa2 and Masami Takei4, 1Nihon University School of Medicine, Tokyo, Japan, 2Division of Heamatology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 3Radiology, St.Marianna University School of Medicine, Kawasaki, Japan, 4Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease and systemic sclerosis, MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Systemic Sclerosis, Diagnostic and Therapeutic Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose

Systemic sclerosis (SSc) is associated with an increased prevalence of cardiac involvement despite often being clinically silent. Cardiac involvement is a major factor in decreasing SSc survival rates because it is associated with a 70% 5-year mortality rate. Cardiac magnetic resonance imaging (CMR) is useful in SSc since it focuses on late gadolinium enhancement (LGE) abnormalities, ventricular morphology, and function. Our study aimed to comprehensively analyze CMR and investigate the association between CMR findings and brain natriuretic peptide (BNP) in SSc patients (pts) without cardiac symptoms.

 Methods

Consecutive female pts with SSc without cardiac symptoms as well as healthy female controls were enrolled. SSc pts and control subjects with no history or clinical findings of systemic and pulmonary hypertension determined by echocardiography, coronary artery disease, valvular heart disease, atrial fibrillation, diabetes mellitus, and dyslipidemia underwent non-contrast or contrast CMR on a 1.5T scanner. Left ventricular (LV) function was measured using LV ejection fraction (EF), end-systolic volume (ESV), end-diastolic volume (EDV), stroke volume (SV), and cardiac output (CO). LV hypertrophy was measured by absolute LV mass (LVM) and LVM index (LVMI) determined by the LVM/body surface area. LGE was obtained to assess myocardial fibrosis. Myocardial inflammation was assessed with black blood T2-WI. Serum BNP concentrations were measured simultaneously in all participants.

Results

We compared 35 SSc pts (mean age, 55.9±7.1 years)—19 with diffuse type and 16 with limited type—with 20 healthy controls (mean age, 56.9±3.1 years). There were no significant differences in characteristics such as age, gender, and cardiovascular risk factors, between SSc and control group. Compared with the control group, the SSc group had a significant higher EDV with tendency toward a high LVMI. There was no difference in EF between the control and SSc groups. SSc with LGE was detected in 16 of 35 pts (46%). The main finding observed in 9 of these 16 (56%) pts was a linear pattern without coronary distribution. A patchy nodular enhancement pattern was observed in 7 pts (44%). LVMI and mass/EDV were significant higher in the LGE (+) group than in the LGE (-) group (P>0.001, P=0.003, respectively). T2-WI imaging showed myocardial inflammation in 6 of 35 pts (17%). The mean BNP level of the SSc group was significantly higher than that of the control group (P=0.04). The mean BNP level of the SSc with LGE group was significantly higher than that of the SSc without LGE group (P=0.023). BNP level was significantly correlated with LVMI and EF in the SSc group (P=0.04, P=0.05, respectively). After adjustment for age, disease duration, and BNP, the SSc with LEG group did not have a modified association with LVMI. 

Conclusion

SSc patients without cardiac symptoms have a high prevalence of cardiac abnormalities. SSc patients with LGE had abnormal morphology associated with LVMI and serum BNP even with a normal EF. Further studies are needed to determine whether CMR abnormalities affect prognosis or treatment strategy.


Disclosure:

K. Sugiyama,
None;

H. Kobayashi,
None;

Y. Kobayashi,
None;

Y. Nagasawa,
None;

N. Ikumi,
None;

T. Nozaki,
None;

H. Inomata,
None;

H. Shiraiwa,
None;

H. Karasawa,
None;

N. Kitamura,
None;

M. Iwata,
None;

Y. Matsukawa,
None;

M. Takei,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/early-detection-of-left-ventricular-morphological-functional-abnormalities-and-myocardial-characteristics-in-systemic-sclerosis-without-cardiac-symptoms-using-cardiac-magnetic-resonance-imaging-a-pr/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology